ETF Managers Group, LLC Invitae Corp Transaction History

ETF Managers Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$24.31 - $33.6 $2.58 Million - $3.56 Million	-105,977 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$26.09 - $40.4 $2.76 Million - $4.28 Million	105,922 Added 192585.45%	105,977 $3.61 Million
Q1 2021 May 17, 2021	SELL	$33.06 - $56.93 $334,567 - $576,131	-10,120 Reduced 99.46%	55 $2,000
Q4 2020 Feb 16, 2021	SELL	$39.09 - $57.4 $192,909 - $283,269	-4,935 Reduced 32.66%	10,175 $450,000
Q3 2020 Nov 16, 2020	BUY	$28.43 - $44.67 $429,577 - $674,963	15,110 New	15,110 $669,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

Stay updated on ETF Managers Group, LLC with notifications on news.